Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Front Endocrinol (Lausanne) ; 13: 1003919, 2022.
Article in English | MEDLINE | ID: mdl-36213269

ABSTRACT

Our aim was to evaluate the markers of endoplasmic reticulum (ER) stress among children and adolescents with obesity in relation to metabolic alterations. Calreticulin (CALR) and PDIA3 circulating levels were assessed on 52 pediatric subjects-26 patients with obesity and 26 normal weight controls (4-18 years)-enrolled in a pilot study. Clinical and metabolic evaluations were performed (BMI-SDS, insulin, and glucose at fasting and during an oral glucose tolerance test, lipid profile, blood pressure), and metabolic syndrome was detected. PDIA3 was higher (p < 0.02) and CALR slightly higher in children with obesity than in controls. PDIA3 was related positively to the Tanner stages. Both PDIA3 and CALR were positively associated with insulin resistance, cholesterol, and triglycerides and the number of criteria identifying metabolic syndrome and negatively with fasting and post-challenge insulin sensitivity. Our preliminary findings suggest the existence of a link between ER stress and metabolic changes behind obesity complications even at the pediatric age. CALR and PDIA3 could be early markers of insulin resistance and dyslipidemia-related ER stress useful to stratify patients at high risk of further complications.


Subject(s)
Insulin Resistance , Metabolic Syndrome , Pediatric Obesity , Adolescent , Biomarkers , Calreticulin/metabolism , Child , Cholesterol , Endoplasmic Reticulum Stress , Glucose , Humans , Insulin/metabolism , Pediatric Obesity/complications , Pilot Projects , Protein Disulfide-Isomerases/metabolism , Triglycerides
2.
Nutrients ; 13(4)2021 Apr 15.
Article in English | MEDLINE | ID: mdl-33920831

ABSTRACT

BACKGROUND: The aim of this study was to determine the effects of a 12-month healthy lifestyle intervention based on diet plus physical activity on cardiovascular structure and function in children and adolescents with obesity; Methods: In this longitudinal study we assessed changes in anthropometric, biochemical and cardiovascular variables in 55 subjects with obesity (6-16 years) before and after a 12-month behavioral program based on Mediterranean diet plus exercise regimen. Subjects were divided in two groups based on negative change in BMI z-score ≥10% from baseline: weight losers (WL) and non-weight losers (NWL); Results: After 12 months, WL showed a significant improvement of metabolic parameters. Treatment was effective in increasing the mitral peak early diastolic velocity E and the E/A ratio. In subjects with a reduction of the number of NCEP-ATPIII metabolic syndrome criteria, lifestyle intervention reduced left ventricular area and volume. Intervention reduced carotid intima-media thickness in subjects showing a decrease of the systemic blood pressure; Conclusions: In children with obesity, cardiovascular impairment could be partially reversed by a healthy lifestyle intervention. To adopt prompt behavioral programs in childhood obesity is crucial both for prevention and treatment of precocious complications and could have an exponential impact on long-term morbidity and mortality.


Subject(s)
Cardiovascular Diseases/therapy , Diet, Healthy/methods , Healthy Lifestyle , Pediatric Obesity/therapy , Weight Reduction Programs/methods , Adolescent , Anthropometry , Cardiovascular Diseases/etiology , Cardiovascular Diseases/physiopathology , Cardiovascular System/physiopathology , Child , Female , Heart Disease Risk Factors , Humans , Longitudinal Studies , Male , Pediatric Obesity/complications , Pediatric Obesity/physiopathology , Treatment Outcome , Weight Loss/physiology
3.
Int J Endocrinol ; 2020: 6035138, 2020.
Article in English | MEDLINE | ID: mdl-32695161

ABSTRACT

PURPOSE: Haptoglobin (Hp) is a protein involved in the acute-phase reaction of inflammation. Humans have three major phenotypes (Hp1-1, Hp1-2, and Hp2-2). Several studies have shown altered Hp regulation in adults with obesity and metabolic alterations. The Hp2-2 phenotype is associated with a high cardiovascular risk. Our aim was to investigate if Hp levels and the Hp2-2 phenotype are associated with glucose metabolism in pediatric obesity. METHODS: We retrospectively studied 192 participants (92 males and 100 females), aged 4-18 years. Clinical and biochemical data were collected. The Hp phenotype (Hp1-1, Hp1-2, and Hp2-2) was identified through Western immunoblot. RESULTS: Subjects carrying Hp1-1, Hp1-2, and Hp2-2 phenotypes were 13.6, 50.8, and 35.6%, respectively. Hp serum, fasting glucose, and insulin levels, as well as HOMA-IR, were similar among groups. Postload glucose and insulin levels (as insulin AUC) were progressively higher from the Hp1-1 to Hp2-2 phenotype. CONCLUSION: To our knowledge, this is the first study on Hp phenotypes conducted in a pediatric population with obesity. We showed that the presence of Hp2 allele is associated with a worse response of glucose load in terms of both glucose and insulin levels. Thus, the Hp2-2 phenotype could predispose in pediatrics, at the same degree of obesity, to a worse glycemic and insulinemic compensation.

4.
Pediatr Infect Dis J ; 39(7): e149-e151, 2020 07.
Article in English | MEDLINE | ID: mdl-32433225

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdotally described. We report the case of a 2-month-old infant with severe acute respiratory syndrome coronavirus 2 infection presenting with fever, tachycardia and elevated interleukin-6, who was diagnosed with myocarditis and treated with immunoglobulins.


Subject(s)
Coronavirus Infections/pathology , Inflammation/virology , Myocarditis/virology , Pneumonia, Viral/pathology , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/metabolism , Coronavirus Infections/virology , Female , Fever/virology , Humans , Immunoglobulins/therapeutic use , Infant , Inflammation/diagnosis , Inflammation/metabolism , Interleukin-6/metabolism , Myocarditis/diagnosis , Pandemics , Pneumonia, Viral/metabolism , Pneumonia, Viral/virology , SARS-CoV-2 , Tachycardia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...